NewsStay Updated with the Latest News from 3billion.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
3billion Announced the Winners of the 2nd End the Diagnostic Odyssey Grant
3billion meet European doctors and researchers of rare disease diagnostics by participating in ESHG 2022
3billion Wins in CAGI6, a Global Artificial Intelligence Genome Interpretation Contest
3billion’s article on EVIDENCE was selected as Top Cited Article in Wiley Online Library
3billion was selected as a business operator for the national project
Rethinking Clinical Practice for Rare Neurodevelopmental Disorders in the Genomic Era